SCHEMBL1126673

SCHEMBL1126673

Cc1cc(C)nc(N(C)CCNc2ccc(NC(=O)C(=O)c3c(-c4ccccc4)cc(C)n3C)cc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 2/20 0.37
MCHR1 Q99705 4/20 0.35
MAPT P10636 5/20 0.35
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
CLK1 P49759 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SLC2A1 P11166 1/20 0.33
THRB P10828 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TGM2 P21980 1/20 0.33
DGAT1 O75907 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1988907 0.90 LMNA (0.38) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1126879 0.89 DGAT1 (0.37) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1993613 0.89 LMNA (0.37) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1989974 0.88 GAA (0.35) LMNASMN1; SMN2HTTMAPTALDH1A1
SCHEMBL1127212 0.88 MCHR1 (0.37) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1644875 0.88 LMNA (0.40) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1647340 0.87 SMN1; SMN2 (0.52) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1988542 0.87 RIPK2 (0.38) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1645531 0.87 LMNA (0.44) LMNASMN1; SMN2HTTMCHR1MAPT
SCHEMBL1989148 0.86 SMN1; SMN2 (0.36) LMNASMN1; SMN2HTTMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 LMNA 3641/4885SMN1; SMN2 2831/4885HTT 776/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 LMNA 3641/4885SMN1; SMN2 2831/4885HTT 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.